Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care  by Tseng, Chih-Peng et al.
Journal of Microbiology, Immunology and Infection (2013) 46, 217e223Available online at www.sciencedirect.com
journal homepage: www.e- jmii .comORIGINAL ARTICLE
Clinical characteristics and outcome of patients
with community-onset Klebsiella pneumoniae
bacteremia requiring intensive careChih-Peng Tseng a, Hau-Shin Wu a,b, Tung-Han Wu c, Yi-Tsung Lin a,d,*,
Chang-Phone Fung a,daDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
bDepartment of Internal Medicine, Taoyuan General Hospital, Department of Health, Executive Yuan,
Taoyuan, Taiwan
cDepartment of Respiratory Therapy, Taipei Veterans General Hospital, Taipei, Taiwan
d Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan




pneumoniae* Corresponding author. Division of In
Shih-Pai Road, Taipei 112, Taiwan.
E-mail address: ytlin8@vghtpe.gov
1684-1182/$36 Copyright ª 2012, Taiw
http://dx.doi.org/10.1016/j.jmii.2012Background: Klebsiella pneumoniae (K. pneumoniae) is the major pathogen of community-
acquired pyogenic infections in Taiwan and can lead to poor prognosis in critically ill
patients complicated with bacteremia. This study investigated the characteristics and
outcome of patients with community-onset K. pneumoniae bacteremia who required inten-
sive care.
Method: Adult patients with community-onset K. pneumoniae bacteremia requiring intensive
care were retrospectively analyzed, compared with those treated in ordinary wards, and
determined for risk factors for infection-related mortality and long-term mortality at
a medical center in Taiwan over a 3-year period.
Results: Among the 309 patients with community-onset K. pneumoniae bacteremia, 58
patients (18.8%) required intensive care. Respiratory tract infection [Odds ratio
(OR) Z 3.67, 95% confidence interval (CI) Z 1.79e7.50, p < 0.001] was the independent risk
factor for ICU admission. Infection-related mortality was 34.5%. Higher APACHE II score
(OR Z 1.43; 95% CI Z 1.02e2.01; p Z 0.041) and underlying malignant neoplasm
(OR Z 35.48; 95% CI Z 2.54e495.57; p Z 0.008) were independent predictors of
infection-related mortality on multivariate logistic regression. One-year overall mortality
was 58.6% and malignant neoplasm was the predisposing factor for poor long-term outcome.fectious Disease, Department of Medicine, Taipei Veterans General Hospital, Number 201, Section 2,
.tw (Y.-T. Lin).
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218 C.-P. Tseng et al.Conclusion: Nearly one fifth of patients with community-onset K. pneumoniae bacteremia
required intensive care and this was associated with high mortality and poor long-term prog-
nosis. Physicians should recognize the distinct characteristics and risk factors for mortality
among these patients.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Klebsiella pneumoniae (K. pneumoniae) is the second most
common cause (behind Escherichia coli) of community- and
hospital-acquired Gram-negative bloodstream infection
(BSI).1 Although nosocomial K. pneumoniae infections occur
worldwide, in the past two decades, geographical differ-
ences have been recognized in the spectrum of community-
acquired infection caused by K. pneumoniae, including
a preponderance of severe invasive disease in Taiwan.2 In
Taiwan, K. pneumoniae is the major cause of community-
onset bacteremia and pyogenic infection.3,4 Furthermore,
K. pneumoniae infection can lead to a poor prognosis in
critically ill patients with bacteremic community-acquired
pneumonia.5
BSI has been associated with increased rates of hospi-
talization, and increased length of stay and hospital
costs.6,7 Community-acquired bacteremia is a common
cause of hospital and intensive care admission, with an
associated ICU crude mortality around 40%.8,9 Despite
advances in the development of adjunctive therapies and
sophisticated life-support facilities, BSI is associated with
a dismal prognosis in critically ill patients.10 Moreover,
bacteremia can lead to increased risk of mortality persist-
ing after 28 days to >1 year in critically ill patients.11
The different characteristics of community-acquired and
nosocomial K. pneumoniae bacteremia have been reported
in the literature.12,13 However, the characteristics of
community-onset K. pneumoniae bacteremia requiring
treatment in the ICU have rarely been reported. In the
literature, only one study found that 11 alcoholic patients
with bacteremic K. pneumoniae pneumonia who needed
ICU management and ventilatory support had rapidly fatal
outcomes.14 Therefore, the aim of our study was to inves-
tigate the clinical manifestations, predictive factors for
mortality, and long-term prognoses of patients with
community-onset K. pneumoniae bacteremia who required
intensive care.Materials and methods
Study design, patient population, and data
collection
This study was a retrospective cohort analysis of consecu-
tive patients with community-onset bacteremia caused by
K. pneumoniae at Taipei Veterans General Hospital,
a tertiary medical center with a 2900-bed capacity.
Patients with community-onset bacteremia caused by
K. pneumoniae were identified by reviewing culture records
from the Department of Microbiology from January 2007through December 2009. We excluded patients aged <18
years. A database was created and the demographic data
and clinical characteristics of the study population were
collected. Potential factors associated with outcome were
identified and statistically analyzed. Data enrolled in this
study included those during the first 30 days after onset of
K. pneumoniae-induced bacteremia or until death. All data
were reviewed by two infectious disease specialists. This
study was approved by Institutional Review Board of Taipei
Veterans General Hospital.
Definitions
An episode of bacteremia was defined as the presence of
>1 blood cultures positive for K. pneumoniae that
contributed to clinical sepsis. When a patient had >1
episode of bacteremia, only the first episode was used in
the analysis. We excluded hospital-acquired bacteremia if
the episode occurred >48 hours after admission15 and
enrolled all other episodes, which were considered as
community-onset bacteremia. Community-onset bacter-
emia was classified as healthcare-associated or community-
acquired infection according to the criteria used by
Friedman et al16 In brief, episodes were classified as
healthcare-associated infection when any of the following
was present: intravenous therapy or specialized nursing
care at home; hemodialysis within 30 days before the BSI;
hospitalization for >2 days in an acute care hospital within
90 days before BSI; or resident in a nursing home or long-
term care facility. Bacteremia was defined as poly-
microbial when >2 different organisms were isolated from
blood cultures. The probable focus of infection was
assessed on the basis of microbiological and clinical find-
ings. Inadequate empiric antimicrobial treatment was
defined as patients who did not receive >1 in vitro active
antimicrobial agent after the index blood culture had been
drawn and before susceptibility results were available.
Infection-related mortality was defined as death within 2
weeks after onset of K. pneumoniae blood culture, in the
absence of known noninfectious causes of death such as
intracranial hemorrhage, myocardial infarction, or pulmo-
nary embolism. Shock was defined as systolic blood pres-
sure <90 mmHg and the need for inotropic agents to
maintain blood pressure. Chronic lung disease was defined
as chronic obstructive pulmonary diseases, bronchiectasis,
or any structural lung diseases with the exception of
bronchogenic carcinoma.
Microbiological methods
Blood culture samples were processed by the BACTEC NR-
660 system (Becton Dickinson, Sparks, MD, USA). All positive
Klebsiella pneumoniae bacteremia requiring ICU 219cultures were examined by Gram staining and subcultured
on blood agar plates and eosin-methylene blue agar plates
for further identification. VITEK 2 system (bioMe´rieux,
Marcy l’Etoile, France) with VITEK 2 GN card was used to
confirm bacterial identification. Antimicrobial suscepti-
bility of K. pneumoniae was tested by standard disk diffu-
sion method. Clinical and Laboratory Standards Institute
(CLSI) criteria were used to define susceptibility or resis-
tance to the antimicrobial agents studied. Extended-
spectrum b-lactamase (ESBL) production was screened
and confirmed in accordance with CLSI standards.17
Statistical analysis
Contingency data were analyzed by two-tailed Chi-square
test or Fisher’s exact test; continuous data were analyzed
by Student t-test or the Mann-Whitney U test. A p value
<0.05 was considered statistically significant; all probabil-
ities were two-tailed. Variables with p value <0.05 in
univariate analyses were subsequently entered in the
multivariate logistic regression model to evaluate the risk
factors for ICU admission and mortality. Shock, respiratory
failure, and altered mental status were not included in the
multivariate logistic regression model because they are
criteria for ICU admission. The Kaplan-Meier method was
used to estimate 1-year all-cause mortality. Patients were
followed from the date of the first episode of K. pneumo-
niae bacteremia until death or last follow-up date. Vari-
ables with a p value <0.05 were entered in Cox
proportional hazards regression to determine factors asso-
ciated with 1-year all-cause mortality. All statistical anal-
yses were performed with SPSS version 18.0.0 for Windows
(SPSS Inc., Chicago, IL, USA).
Results
Clinical characteristics of patients with
community-onset K. pneumoniae bacteremia
requiring intensive care
During the 3-year study period, 309 consecutive patients
with community-onset K. pneumoniae bacteremia, including
175 community-acquired and 134 healthcare-associated
infections, were identified. Among these, 58 patients
(18.8%) required intensive care during the study period and
30 patients had healthcare-associated infections. Diabetes
mellitus (DM) and malignant neoplasm were the most
common underlying diseases, and respiratory tract infection
was the most common source of bacteremia in the patients
requiring intensive care. Underlying DM was more common
in community-acquired than in healthcare-associated
infection [15/28 (53.6%) vs. 6/30 (20%); p Z 0.008]. On
the other hand, malignant neoplasm was more frequent in
patients with healthcare-associated compared with
community-acquired infections [18/30 (60.0%) vs. 5/28
(17.9%); p Z 0.001]. We compared the clinical character-
istics between patients treated in the ordinary ward
(nZ 251) versus those requiring intensive care (nZ 58), as
shown in Table 1. Older patients (74.2  13.8 vs.
69.8  15.3, respectively; p Z 0.044), those with chronic
lung disease (31.0% vs. 8.8%, respectively; p Z 0.01), andthose with respiratory tract infection (48.3% vs. 13.5%,
respectively; p < 0.001) had a significantly higher rate of
ICU admission. By contrast, patients with biliary tract
infection (BTI) had a significantly lower rate of requiring
intensive care (10.3% vs. 28.7%; p Z 0.006). Logistic
regression analysis revealed that respiratory tract infection
[Odds Ratio (OR) Z 3.67, 95% confidence interval (CI) Z
1.79e7.50, p < 0.001] was the independent risk factor
mandating intensive care. Infection-related mortality rate
in patients requiring intensive care was significantly higher
than in those treated in ordinary wards (34.5% vs. 4.0%;
p < 0.001).
Predictive factors for infection-related mortality
and 1-year prognosis among patients requiring
intensive care
We compared the clinical characteristics between the
survivors (n Z 38) and nonsurvivors (n Z 20), as shown in
Table 2. There was no significant difference in sex, age,
polymicrobial infection, resistance strain, and adequacy of
antibiotic use. Patients with higher Acute Physiology and
Chronic Health Evaluation (APACHE) II scores (30.2  6.1 vs.
23.5  5.4, respectively; p < 0.001), healthcare-associated
infection (80.0% vs. 36.8%; p Z 0.004), underlying malig-
nant neoplasm (80.0% vs. 18.4%; p < 0.001), initial presen-
tation of respiratory failure (90.0% vs. 55.3%; p Z 0.017),
altered mental status (75.0% vs. 36.8%; p Z 0.013), and
lower leukocyte count (10.2  9.9 vs. 17.6  13.9  109/L,
p Z 0.038) had a significantly higher risk of mortality. All
patients with liver abscesses treated in the ICU had
a favorable outcome (0% vs. 21.1%; p Z 0.041). Logistic
regression analysis (Table 3) revealed that higher APACHE II
score (OR Z 1.43; 95% CI Z 1.02e2.01; p Z 0.041) and
underlying malignant neoplasm (OR Z 35.48; 95%
CIZ 2.54e495.57; pZ 0.008) were independent predictors
of mortality.
Overall, the 1-yearmortality in these patients admitted to
ICU was 58.6% (nZ 34). After analysis of the same variables
listed in Table 2, we found that 1-year morality-related
potential risks included healthcare-associated bacteremia
(p Z 0.01), higher APACHE II score (p < 0.001), malignant
neoplasm (p < 0.001), respiratory failure (p Z 0.025),
altered mental status (pZ 0.001) and inappropriate antibi-
otics use (p Z 0.042), as showed in Table 4. The
KaplaneMeier survival curves demonstrated that patients
with an underlying malignant neoplasm had higher mortality
than those without a malignant neoplasm (p < 0.001, by log-
rank test) (Fig. 1). Cox hazards proportional regression
revealed that the risk for 1-year all-cause mortality was
underlying malignant neoplasm (Hazard Ratio Z 3.14, 95%
CIZ 1.36e7.26, pZ 0.007).
Discussion
A previous study demonstrated that critically ill patients
with nosocomial K. pneumoniae bacteremia tended to
experience acute renal failure, hemodynamic instability,
a longer length of ICU stay, and longer ventilator depen-
dence.18 However, few studies regarding the characteristics
and outcome of critically ill patients with community-onset
Table 1 Comparison of clinical features of patients with community-onset K. pneumoniae bacteremia treated in an ordinary
ward and in the ICUa
Clinical feature Overall (n Z 309) Ordinary ward (n Z 251) ICU admission (n Z 58) pb
Age (y) 70.6  15.1 69.8  15.3 74.2  13.8 0.044
Male 208 (67.3) 163 (64.9) 45 (77.6) 0.090
Healthcare-associated 134 (43.4) 104 (41.4) 30 (51.7) 0.201
Underlying disease
Diabetes mellitus 121 (39.2) 100 (39.8) 21 (36.2) 0.718
Liver cirrhosis 31 (10.0) 24 (9.6) 7 (12.1) 0.741
Chronic lung disease 40 (12.9) 22 (8.8) 18 (31.0) 0.010
Alcoholism 25 (8.1) 18 (7.2) 7 (12.1) 0.281
Congestive heart failure 28 (9.1) 21 (8.4) 7 (12.1) 0.528
Chronic kidney disease (Cr > 2 mg/dL) 26 (8.4) 18 (7.2) 8 (13.8) 0.116
CNS disease 73 (23.6) 57 (22.7) 16 (27.6) 0.538
Autoimmune disease 9 (2.9) 7 (2.8) 2 (3.4) 0.678
Transplantation 5 (1.6) 5 (2.0) 0 (0) 0.588
Malignant neoplasm 108 (35.0) 85 (33.9) 23 (39.7) 0.405
Initial presentation
Shock 83 (26.9) 39 (15.5) 44 (75.9) <0.001
Respiratory failure 45 (14.6) 6 (2.4) 39 (67.2) <0.001
Altered mental status 58 (18.8) 29 (11.6) 29 (50.0) <0.001
Onset of symptoms (d) 3.3  4.8 3.4  5.2 2.8  2.9 0.265
Infectious focus
Meningitis 1 (0.3) 0 (0) 1 (1.7) 0.188
Respiratory tract infection 62 (20.1) 34 (13.5) 28 (48.3) <0.001
Liver abscess 45 (14.6) 37 (14.7) 8 (13.8) 0.854
Biliary tract infection 78 (25.2) 72 (28.7) 6 (10.3) 0.006
Intraabdominal infection 13 (4.2) 11 (4.4) 2 (3.4) >0.999
Urinary tract infection 81 (26.2) 70 (27.9) 11 (19.0) 0.220
Skin and soft tissue infection 8 (2.6) 5 (2.0) 3 (5.2) 0.174
Primary 29 (9.4) 23 (9.2) 6 (10.3) 0.977
Polymicrobial 42 (13.6) 34 (13.5) 8 (13.8) >0.999
ESBL strain 15 (4.9) 11 (4.4) 4 (6.9) 0.494
Inappropriate antibiotic use 6 (1.9) 2 (0.8) 4 (6.9) 0.013
Infection-related mortality 30 (9.7) 10 (4.0) 20 (34.5) <0.001
CNS Z central nervous system; Cr Z creatinine; ESBL Z extended-spectrum beta-lactamase; ICU Z intensive care unit.
a Data are presented as mean  standard deviation or frequency with percentage (%).
b These analyses were conducted by comparing patients treated in an ordinary ward with those admitted to the ICU.
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knowledge, this is the first retrospective study to focus on
patients with community-onset K. pneumoniae bacteremia
requiring intensive care. We found that the ICU admission
rate of patients with K. pneumoniae bacteremia was 18.8%
and mortality rate was 34.5%. The prevalence of respiratory
tract infection was significantly higher in patients admitted
to the ICU than those in ordinary wards. Respiratory tract
infection was also the independent risk factor for patients
admitted to the ICU, possibly reflecting the fulminant course
of bacteremic pneumonia caused by K. pneumoniae, as
shown in our previous study.5
Consistent with previous reports regarding bacteremia in
the ICU, we also found that the APACHE II score was inde-
pendently associated with mortality.9,19 In the present
study, the mortality of K. pneumoniae bacteremia patients
in the ICU was high. With much improvement of critical
care in recent years, although patients with a high APACHE
II score (mean Z 23.45  5.35) can survive, patients withmore severe disease (mean Z 30.15  6.11) still have
difficulty surviving, suggesting that host factors are impor-
tant for the prognosis of K. pneumoniae bacteremia.
Malignant neoplasm was another factor independently
associated with mortality in the ICU in the current study.
Our cohort had a higher proportion of malignant neoplasms
than the previous study,12 which might be due to the
different study period. Although we did not find that
malignancy predisposed to mortality in critically ill patients
with community-onset bacteremia in the literature, the
prevalence of malignant neoplasms in the current study
might play an important role in the outcome of K. pneu-
moniae bacteremia. In the current study, most (80%) of the
mortality in community-onset K. pneumoniae bacteremic
patients requiring intensive care, was in cancer patients,
which corresponded to the poor prognosis in cancer
patients with nosocomial bacteremia due to K. pneumoniae
in our previous study.20 In addition, although we failed to
demonstrate the prognostic significance of appropriate
Table 2 Risk factors for infection-related mortality in patients with community-onset Klebsiella pneumoniae bacteremia
requiring intensive carea
Clinical feature Overall (n Z 58) Survivor (n Z 38) Mortality (n Z 20) pb
Age (y) 74.2  13.8 73.6  14.2 75.4  13.4 0.648
Male 45 (77.6) 29 (76.3) 16 (80.0) >0.999
APACHE II score 25.8  6.4 23.5  5.4 30.2  6.1 <0.001
Healthcare-associated 30 (51.7) 14 (36.8) 16 (80)c 0.004
Underlying disease
Diabetes mellitus 21 (36.2) 16 (42.1) 5 (25.0) 0.317
Liver cirrhosis 7 (12.1) 4 (10.5) 3 (15.0) 0.683
Chronic lung disease 18 (31.0) 14 (36.8) 4 (20.0) 0.308
Alcoholismd 7 (12.1) 6 (15.8) 1 (5.0) 0.403
Congestive heart failure 7 (12.1) 5 (13.2) 2 (10.0) >0.999
Chronic kidney disease (Cr > 2 mg/dL) 8 (13.8) 5 (13.2) 3 (15.0) 0.345
CNS disease 16 (27.6) 12 (31.6) 4 (20.0) 0.530
Autoimmune disease 2 (3.4) 2 (5.3) 0 (0) 0.540
Malignant neoplasm 23 (39.7) 7 (18.4) 16 (80.0) <0.001
Initial presentation
Shock 44 (75.9) 27 (71.1) 17 (85.0) 0.338
Respiratory failure 39 (67.2) 21 (55.3) 18 (90.0) 0.017
Altered mental status 29 (50.0) 14 (36.8) 15 (75) 0.013
Onset of symptoms in days 2.8  2.9 3.2  3.4 2.1  1.5 0.070
WBC count (109/L) 15.1  13.0 17.6  13.9 10.2  9.9 0.038
Platelet count (109/L) 135  99 139  102 118  85 0.649
C-reactive protein (mg/dL) 19.0  9.8 19.6  10.2 16.0  7.1 0.187
Infectious focus
Meningitis 1 (1.7) 1 (2.6) 0 (0) >0.999
Respiratory tract infection 28 (48.3) 17 (44.7) 11 (55.0) 0.640
Liver abscess 8 (13.8) 8 (21.1) 0 (0) 0.041
Biliary tract infection 6 (10.3) 4 (10.5) 2 (10.0) >0.999
Intraabdominal infection 2 (3.4) 1 (2.6) 1 (5.0) >0.999
Urinary tract infection 11 (19.0) 10 (26.3) 1 (5.0) 0.077
Skin and soft tissue infection 3 (5.2) 1 (2.6) 2 (10.0) 0.271
Primary 6 (10.3) 3 (7.9) 3 (15.0) 0.405
Polymicrobial 8 (13.8) 6 (15.8) 2 (10.0) 0.701
ESBL strain 4 (6.9) 3 (7.9) 1 (5.0) >0.999
Inappropriate antibiotic use 4 (6.9) 2 (5.3) 2 (10.0) 0.602
APACHEZ Acute Physiology and Chronic Health Evaluation; CNSZ central nervous system; ESBLZ extended-spectrum beta-lactamase;
WBC Z white blood cell.
a Data are presented as mean  standard deviation or frequency with percentage (%).
b These analyses were conducted comparing the survivor and mortality group.
c 13 patients had an underlying malignant neoplasm (81.3%).
d Cases with alcoholism include 1 of UTI, 1 of peritonitis, 1 of pneumonia, and 4 of liver abscess. The case of peritonitis fulfilled the
definition of infection-related mortality.
Table 3 Independent risk factors associated with
infection-related mortality in the ICU due to community-
onset K. pneumoniae bacteremia
Factors Odds ratio (95% CI) p
APACHE II score 1.43 (1.12e2.01) 0.041
Healthcare-associated 7.79 (0.65e93.72) 0.106
Malignant neoplasm 35.48 (2.54e495.57) 0.008
Respiratory failure 11.75 (0.28e495.85) 0.197
Altered mental status 1.21 (0.06e241.76) 0.902
WBC count (109/L) 1.00 (1.00e1.00) 0.063
APACHE Z Acute Physiology and Chronic Health Evaluation;
CI Z confidence interval; WBC Z white blood cell.
Klebsiella pneumoniae bacteremia requiring ICU 221empiric antibiotics in ICU patients, we do not exclude the
possibility that the relatively small sample size lacked
statistical power to differentiate among the impact of
different antibiotics on survival.
DM is a well-known risk factor for K. pneumoniae infec-
tion. DM accounted for 49% among the patients of
community-acquired K. pneumoniae bacteremia in
a previous study.12 In our study, DM was the most common
underlying disease (39.2%) among all community-onset
bacteremia. However, diabetes did not predispose patients
to requiring ICU admission or influence their mortality.
Whether diabetes has been associatedwith aworse prognosis
with Enterobacteriaceae bacteremia is controversial.21,22
Information about the effect of diabetes on the prognosis
Table 4 Risk factors for 1-year mortality in the ICU due to community-onset K. pneumoniae bacteremia
Factor Univariate analysis Multivariate analysis
HR 95% CI p Adjusted HR 95% CI p
Healthcare-associated infection 2.54 1.25e5.16 0.010 1.24 0.55e2.78 0.610
APACHE II score 1.12 1.06e1.19 <0.001 1.06 0.997e1.129 0.063
Malignant neoplasm 3.52 1.76e7.05 <0.001 3.14 1.36e7.26 0.007
Respiratory failure 2.49 1.12e5.54 0.025 1.84 0.73e4.60 0.196
Altered mental status 3.40 1.64e7.05 0.001 1.74 0.71e4.29 0.230
Inappropriate antibiotic use 3.02 1.04e8.74 0.042 2.25 0.64e7.94 0.206
APACHE Z Acute Physiology and Chronic Health Evaluation; CI Z confidence interval; HR Z hazard ratio.
222 C.-P. Tseng et al.of patients with bacteremia in general, and with K. pneu-
moniae bacteremia in particular, is limited. More research is
needed to delineate relations between diabetes and K.
pneumoniae bacteremia. Jong et al found that 11 alcoholic
patients with bacteremic K. pneumoniae pneumonia, who
needed ICUmanagement, had a rapid fatal outcome.14 In our
study, only one of the seven alcoholic cases died of infection.
The different focus of bacteremia between the current study
and the previous one might account for the different results.
K. pneumoniae is the most commonly isolated microor-
ganism in liver abscesses in Taiwan.2 It has a potential
metastatic infection and can result in endophthalmitis or
central nervous system infection.23,24 In a study by Chen
et al, the overall mortality of patients with a liver abscess
caused by K. pneumoniae, requiring intensive care, was
23%.25 In the present study, bacteremic liver abscess was
not associated with a higher prevalence of ICU admission
and the outcome of bacteremic liver abscess in the ICU was
favorable. We could not compare the APACHE II score
between the two studies, which might account for the
different outcome. Management of liver abscesses hasFigure 1. Comparison of KaplaneMeier survival curves, at 1
year, between patients requiring intensive care with under-
lying malignancy and those without malignancy (p < 0.001, by
log-rank test).recently improved in Taiwan because of increased physician
awareness; different study periods may be another reason
for the discordance.26
BSI-associated sepsis and septic shock are associated
with an increased risk of mortality persisting after 28 days
to >1 year.11 While much of the mortality attributable to
bloodstream infection occurs acutely within days to weeks
after onset, organ dysfunction and other complications may
lead to significant mortality months or years later.27 Long-
term follow-up better defines the burden of illness associ-
ated with these syndromes. Herein, we present the first
study of K. pneumoniae bacteremia in critically ill adults
which evaluates the long-term (1-year) outcomes associ-
ated with these conditions. Less than 50% patients survived
beyond 1 year after K. pneumoniae bacteremia, and
malignant neoplasm was the only independent predictor of
long-term mortality, suggesting that long-term mortality is
more a question of underlying conditions, than of bacter-
emia per se. Although it is important to note that the late
deaths were not directly attributable to the original
bloodstream infection, our data support the notion that
future studies should include longer-term endpoints, so as
to better understand the natural history of sepsis and the
effects of interventions on morbidity.27
In conclusion, approximately one-fifth of patients with
community-onset K. pneumoniae bacteremia required
intensive care in our institution throughout the study
period. Respiratory tract infection was the only indepen-
dent risk factor for ICU admission. Mortality among patients
admitted to the ICU was high (34.5%), and a higher APACHE
II score and underlying malignant neoplasm were indepen-
dent risk factors for infection-related mortality. Overall,
1-year mortality in these patients admitted to the ICU was
58.6%. Physicians should recognize the distinct character-
istics and risk factors for mortality among these patients.Acknowledgments
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